Magellan Health, Inc. ( MGLN) Stock. Should you Buy or Sell? $ 94.99
94.99 (50.00 %)
Magellan Health, Inc. AnalysisUpdated on 10-09-2022
|Volume Avg.||$143.02 thousand|
|Market Cap||$2.5 B|
|52 Week Range||$82.94 - $99.355|
Magellan Health, Inc. opened the day at $94.99 which is +'50.00 % on yesterday's close. Magellan Health, Inc. has a 52 week high of $99.355 and 52 week low of $82.94, which is a difference of $16.415. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $2.5 B and total net profit is $4577531000 which means the company is trading at 0.55 times profit to market capitalization. Theoretically, if you were to buy Magellan Health, Inc. for $2.5 B, it would take 15 years to get your money back. Magellan Health, Inc. are in the Healthcare Plans space which will have a sweet spot and industry standard for net profit multiples.
Magellan Health, Inc. Stock Forecast - Is Magellan Health, Inc. a Buy or Sell?
|DCF Score||Strong Buy|
|PE Score||Strong Buy|
|PB Score||Strong Buy|
|Overall Recommendation||Strong Buy|
Growth and Value
|Net Profit Margin||0.062|
Valuing Magellan Health, Inc.
|Price Book Value Ratio||1.289||Price To Book Ratio||1.289|
|Price To Sales Ratio||0.517||Price Earnings Ratio||8.395|
How liquid is Magellan Health, Inc.
|Debt Ratio||0.423||Debt Equity Ratio||0.734|
|Long Term Debt To Capitalization||0.211||Total Debt To Capitalization||0.212|
Latest news about Magellan Health, Inc.
Magellan's (MGLN) unit - Magellan Healthcare - partners with NeuroFlow to launch a wellbeing solution for empowering MGLN's members in independently managing their health issues.
Magellan's (MGLN) unit - Magellan Healthcare - joins forces with DUOS to offer a digital solution for easing the independent living of older adults at homes.
AVYA, TALO, VIOT, SBUX, and MGLN have been added to the Zacks Rank #5 (Strong Sell) List on December 20, 2021
COLD, BRKS, CURO, FSTR, and MGLN have been added to the Zacks Rank #5 (Strong Sell) List on November 17, 2021.
PHOENIX--(BUSINESS WIRE)--Magellan Health brings together an accomplished team of healthcare experts to serve on the Magellan Health Studio Advisory Council.
About Magellan Health, Inc.
Magellan Health, Inc., together with its subsidiaries, provides healthcare management services in the United States. The company operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans; and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine. It also contracts with state Medicaid agencies, and the centers for Medicare and Medicaid services to manage care for beneficiaries under Medicaid and Medicare programs, such as healthcare and long-term support services through its network of medical and behavioral health professionals, clinics, hospitals, nursing facilities, home care agencies, and ancillary service providers. The Pharmacy Management segment comprises products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Further, it offers pharmacy benefit management services, such as pharmaceutical dispensing services; pharmacy benefit administration for state Medicaid and other government sponsored programs; clinical and formulary management programs; medical pharmacy management programs; and programs for the integrated management of specialty drugs that treat complex conditions. In addition, the company provides services to health plans and managed care organizations, employers, labor unions, third party administrators, state governments, military and governmental agencies, exchanges, brokers, and consultants. Magellan Health, Inc. was incorporated in 1969 and is headquartered in Phoenix, Arizona. As of January 4, 2022, Magellan Health, Inc. operates as a subsidiary of Centene Corporation.